MedTrace Logo

Effects of Nicotine in Tobacco Smokers

NCT03651869 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 221

Last updated 2023-07-13

No results posted yet for this study

Summary

This study will examine mechanisms linking Obsessive-Compulsive Disorder symptomatology to tobacco dependence.

Conditions

  • Smoking, Tobacco
  • Smoking (Tobacco) Addiction

Interventions

DRUG

Cigarette 1

Cigarette containing between 0mg nicotine and the conventional amount of nicotine (0.8mg)

DRUG

Cigarette 2

Cigarette containing between 0mg nicotine and the conventional amount of nicotine (0.8mg)

DRUG

Patch 1

A patch containing between 0mg nicotine and the conventional amount of nicotine (21mg)

DRUG

Patch 2

A patch containing between 0mg nicotine and the conventional amount of nicotine (21mg)

Sponsors & Collaborators

  • Illinois Institute of Technology

    collaborator OTHER

  • University of Southern California

    lead OTHER

Principal Investigators

  • Adam M Leventhal, PhD · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-04
Primary Completion
2023-03-23
Completion
2023-03-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651869 on ClinicalTrials.gov